Boston Scientific (BSX) Akcie Kurz
Boston Scientific Kurz
Tržby rostly o 5,1 % ročně za posledních 19 let na 20,07 Mld. USD. Zisk na akcii rostl o 14,1 % ročně za posledních 14 let. čistá marže společnosti Boston Scientific je nyní 14,4 %, nahoru z 8,7 % před několika lety. Medián cílové ceny analytiků je 63,50 USD, tedy nad aktuální cenu o 46,0 %. Z 37 analytiků jich 24 doporučuje nákup — celkový konsenzus je Koupit.
Cena akcie Boston Scientific
Tato data přes Eulerpool API
100 000 požadavků/měs. zdarma · bez karty
Obchodní model Boston Scientific a analýza akcií
Nejčastější otázky týkající se akcie Boston Scientific
The main competitors of Boston Scientific Corp in the market include Medtronic, Johnson & Johnson, Abbott Laboratories, and Edwards Lifesciences.
Boston Scientific Corp is a global medical technology company. Its business model revolves around developing innovative medical solutions that enhance patient care and healthcare outcomes. Boston Scientific Corp manufactures and markets a broad range of medical devices used in various specialties, such as cardiology, urology, endoscopy, and neuromodulation. The company's commitment to research and development enables it to introduce advanced technologies and therapies that address unmet clinical needs. Boston Scientific Corp also focuses on collaborations and partnerships to expand its product portfolio, improve access to healthcare, and provide high-quality medical devices to patients worldwide.
Boston Scientific Corp is primarily active in the medical equipment and supplies industry.
Boston Scientific Corp is a renowned medical technology company based in Marlborough, Massachusetts. Established in 1979, it has become a global leader in the development, manufacturing, and marketing of innovative medical devices. With a focus on advancing patient care, Boston Scientific Corp offers a wide range of products for various medical specialties, including interventional cardiology, urology, endoscopy, and neuromodulation. The company's history showcases its commitment to medical breakthroughs and improving the lives of patients worldwide. Boston Scientific Corp's dedication to cutting-edge technology and strategic acquisitions has allowed it to maintain a prominent position in the healthcare industry.
Boston Scientific Corp has achieved significant milestones throughout its history. Some notable achievements include the development of the Taxus Express, a groundbreaking drug-eluting stent that revolutionized the treatment of coronary artery disease. Additionally, the acquisition of Guidant Corporation strengthened Boston Scientific's position in the field of cardiac rhythm management. The company's innovative products, such as the Watchman Left Atrial Appendage Closure device, have provided improved treatment options for patients with atrial fibrillation. Boston Scientific Corp continues to innovate and make advancements in medical technologies, helping to improve patient outcomes worldwide.
Boston Scientific Corp is primarily present in several countries and regions worldwide. The company has a strong global presence, with significant operations in the United States, Europe, Asia-Pacific, Latin America, and the Middle East. Its diverse market reach spans across more than 130 countries, enabling Boston Scientific Corp to provide innovative medical solutions and technologies to a vast range of patients and healthcare professionals worldwide.
Boston Scientific Corp represents values of innovation, collaboration, and patient-centricity. With a strong corporate philosophy focused on improving patients' lives, the company is committed to developing and delivering innovative medical solutions. Boston Scientific Corp's dedication to collaboration extends to its partnerships with healthcare professionals and institutions, helping to address unmet needs and improve patient outcomes. By prioritizing patient-centric care, the company ensures that its products and services are designed to provide effective and meaningful treatments. Boston Scientific Corp's continued commitment to innovation and collaboration underscores its mission to transform lives through medical advancements in a rapidly evolving healthcare landscape.
Analytici aktuálně stanovují průměrnou cílovou cenu 66,50 USD pro akcii Boston Scientific (medián: 63,50 USD), tedy +52,9 % vůči poslední ceně. Konsensus vychází z 37 hodnocení analytiků.
37 analytiků aktuálně hodnotí akcii Boston Scientific: 24 doporučuje koupit, 12 držet a 1 prodat. Pro rok 2026 analytici očekávají u Boston Scientific tržby 21,09 Mld. USD a zisk na akcii 3,17 USD.
Při aktuálním kurzu se akcie Boston Scientific obchoduje za 38,86 EUR (43,50 USD).
Akcie Boston Scientific (BSX) je kótována na 10 burzách, mimo jiné: NYSE (BSX), London (0HOY.L), SIX (Zürich) (BSX.SW), XETRA (BSX.DE), Frankfurt (BSX.F), München (BSX.MU), Düsseldorf (BSX.DU), Wien (BSXC.VI).
The Boston Scientific Corporation is a medical technology company that specializes in the manufacturing and development of medical devices. The company was founded in Massachusetts in 1979 and operates globally today. Its business model includes various divisions that focus on different medical specialties. The Cardiac Rhythm Management division of Boston Scientific is involved in the manufacturing of devices for the treatment of heart rhythm disorders. This includes products such as implantable defibrillators, pacemakers, and accessories. The products in this division are of high quality and have an excellent track record in treating patients with severe heart problems. The Interventional Cardiology division of Boston Scientific specializes in the manufacturing of products used in the treatment of heart diseases. This includes balloon catheters, stents, and catheter ablation systems. These products are typically minimally invasive and allow for a quick restoration of normal heart rhythm in patients. The Interventional Radiology division of Boston Scientific is focused on the manufacturing of products for the diagnosis and treatment of vascular diseases. The company produces catheters, stents, and embolization accessories, among other things. Additionally, Boston Scientific is also specialized in the development of products for the treatment of chronic pain. The products in this division include implantable pain therapy systems, neurostimulators, and accessories. These devices can alleviate patients' pain and improve their quality of life. The company is also specialized in the field of urology, including products for the treatment of conditions such as urinary incontinence and benign prostatic hyperplasia. Boston Scientific produces mesh implants and devices aimed at improving bladder control. Furthermore, the company has a division dedicated to gastrointestinal diseases, including products for the treatment of conditions like colorectal cancer and gastrointestinal bleeding. The portfolio includes endoscopes, balloon catheters, and other devices for the treatment of digestive tract disorders. Boston Scientific is committed to providing its customers with the best products. Product development is strongly focused on meeting the needs of patients and doctors. By continually developing new products, the company can expand its market position and maintain its leading position in the medical technology industry.
Tržby očekávané za Boston Scientific činí 21,09 Mld. USD. Tato hodnota je založena na aktuálních finančních údajích a odráží výkonnost společnosti.
Zisk očekávané za Boston Scientific činí 4,74 Mld. USD. Čistý zisk odráží ziskovost společnosti po odečtení všech nákladů.
Poměr ceny k zisku (P/E) Boston Scientific je aktuálně 13,73. Poměr P/E porovnává aktuální cenu akcie se ziskem na akcii a pomáhá investorům posoudit ocenění akcie Boston Scientific.
Poměr ceny k tržbám (P/S) Boston Scientific je aktuálně 3,09. Poměr P/S porovnává tržní kapitalizaci s ročními tržbami a slouží jako metrika ocenění akcie Boston Scientific.
Score kvality pro Boston Scientific je 5/10.
ISIN Boston Scientific je US1011371077. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.
WKN Boston Scientific je 884113. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.
Ticker Boston Scientific je BSX. Symbol tickeru se používá k obchodování akcií Boston Scientific na burze.
Boston Scientific akcie
Boston Scientific Peer Group
Boston Scientific Ticker
Boston Scientific FIGI
Všechny fundamentální údaje o Boston Scientific v podrobné analýze
Naše analýzy akcií společnosti Boston Scientific zahrnují důležité finanční ukazatele jako obrat, zisk, P/E poměr, P/S poměr, EBIT, stejně jako informace o dividendách. Dále zkoumáme aspekty jako akcie, tržní kapitalizaci, dluhy, vlastní kapitál a závazky společnosti Boston Scientific. Pokud hledáte podrobnější informace o těchto tématech, nabízíme vám na našich podstránkách rozsáhlé analýzy: